2025 Wrapped

𝗦𝗲𝗻𝘀𝗼𝗿𝗲 𝟮𝟬𝟮𝟱 𝗪𝗿𝗮𝗽𝗽𝗲𝗱.
2025 was a year of material progress for Sensore, marking a transition from validation to execution and building the foundations for clinical and commercial scale.

Over the year we have:
• Secured our first core patent
• Raised £580k across grant and equity funding
• Established and initiated a clear regulatory pathway with expert support from London Institute for Healthcare Engineering
• Completed independent performance and durability validation with NPL
• Secured our first paid commercial pilots
• Launched Sensore publicly at national industry and clinical events
• Strengthened the team across regulatory, clinical and commercial leadership

These milestones put Sensore in a strong position to scale in 2026, focused on delivering our funded clinical usability study, preparing UKCA submission and converting early pilots - towards a planned launch in 2027.

𝗢𝘂𝗿 £𝟵𝟱𝟬𝗸 𝗦𝗲𝗲𝗱 𝗿𝗼𝘂𝗻𝗱 𝗶𝘀 𝗻𝗼𝘄 𝗼𝗽𝗲𝗻 (𝗘𝗜𝗦 𝗔𝗽𝗽𝗿𝗼𝘃𝗲𝗱)
We are engaging with aligned EIS investors to anchor our seed round and welcome direct conversations and warm introductions.